| Literature DB >> 25772401 |
Jacob Lutjeboer1, Mark Christiaan Burgmans, Kaman Chung, Arian Robert van Erkel.
Abstract
PURPOSE: Interventional radiology (IR) procedures are associated with high rates of preparation and planning errors. In many centers, pre-procedural consultation and screening of patients is performed by referring physicians. Interventional radiologists have better knowledge about procedure details and risks, but often only get acquainted with the patient in the procedure room. We hypothesized that patient safety (PS) and patient satisfaction (PSAT) in elective IR procedures would improve by implementation of a pre-procedural visit to an outpatient IR clinic.Entities:
Mesh:
Year: 2015 PMID: 25772401 PMCID: PMC4422862 DOI: 10.1007/s00270-015-1069-4
Source DB: PubMed Journal: Cardiovasc Intervent Radiol ISSN: 0174-1551 Impact factor: 2.740
Fig. 1Flow diagram showing total number of patients screened, exclusion numbers and reasons, and per group analysis. RA research assistant, PA physician assistant
Baseline characteristics for control and experimental group
| Characteristic | Control group ( | Experimental group ( |
|
|---|---|---|---|
| Age (mean ± SD) | 56.6 ± 16.1 | 57.9 ± 14.7 | 0.514 |
| Sex ( | 0.050 | ||
| Male | 63 | 77 | |
| Female | 47 | 33 | |
| Questionnaires response ( | 88 (80.0 %) | 77 (70.0 %) | |
| Type of procedure ( | 0.011 | ||
| Ablations | 27 (24.5 %) | 29 (26.5 %) | |
| Biopsy | 33 (30.0 %) | 43 (39.1 %) | |
| Drainages | 15 (13.5 %) | 4 (3.6 %) | |
| Embolization | 15 (13.5 %) | 24 (21.8 %) | |
| Central venous access | 15 (13.5 %) | 5 (4.5 %) | |
| Stents/PTA non arterial | 5 (4.5 %) | 5 (4.5 %) |
Key point information and outpatient screening list
| Information | Discussed | ||
|---|---|---|---|
| Procedure | |||
| Indication | □ Yes | □ No | |
| Method of anaesthesia | □ Yes | □ No | |
| Procedure details explained | □ Yes | □ No | |
| Procedure length discussed | □ Yes | □ No | |
| Expected treatment outcome explained | □ Yes | □ No | |
| Complications | |||
| Bleeding | □ Yes | □ No | □ N.A. |
| Infection | □ Yes | □ No | □ N.A. |
| Thrombus/embolus | □ Yes | □ No | □ N.A. |
| Neurogenic complications | □ Yes | □ No | □ N.A. |
| Non-Target | □ Yes | □ No | □ N.A. |
| Allergy | □ Yes | □ No | □ N.A. |
| Pneumothorax | □ Yes | □ No | □ N.A. |
| Other | □ Yes | □ No | □ If yes, specify: |
| Post-procedure | |||
| Puncture site care | □ Yes | □ No | □ N.A. |
| Drain management | □ Yes | □ No | □ N.A. |
| Suture management | □ Yes | □ No | □ N.A. |
| Pain management | □ Yes | □ No | □ N.A. |
| Admission time | □ Yes | □ No | □ N.A. |
| Other | □ Yes | □ No | □ If yes, specify: |
| Screening | Checked | ||
| Contra-indications | □ Yes | □ No | |
| Contrast allergy | □ Yes | □ No | |
| Renal function | □ Yes | □ No | |
| Anti-coagulation | □ Yes | □ No | |
| Other medication | □ Yes | □ No | |
| Other allergy | □ Yes | □ No | |
Fig. 2IR patient safety checklist
Questionnaire outcomes: average Likert score per dimensions of patient satisfaction, for separate questions and overall score per group
| Characteristic | Control group ( | Experimental group ( |
|
|---|---|---|---|
| Dimensions of patient satisfaction | |||
| Interpersonal aspects | 2.73 ± 0.402 | 2.89 ± 0.291 | 0.005 |
| Information and communication | 2.57 ± 0.571 | 2.83 ± 0.262 | <0.001 |
| Participation | 2.38 ± 0.754 | 2.59 ± 0.613 | 0.067 |
| Separate questions (mean ± SD) | |||
| Interpersonal aspect | |||
| Was doctor knowledgeable? | 2.88 ± 0.357 | 2.87 ± 0.380 | 0.770 |
| Information and communication | |||
| Information was consistent with the actual treatment? | 2.57 ± 0.770 | 2.75 ± 0.520 | 0.075 |
| Information about duration of the treatment in accordance with the actual treatment? | 2.34 ± 0.887 | 2.53 ± 0.644 | 0.120 |
| Properly informed about preparation of the treatment | 2.51 ± 0.919 | 2.65 ± 0.762 | 0.262 |
| Overall patient satisfaction | |||
| Patient satisfaction without separate questions | 2.45 ± 0.398 | 2.67 ± 0.301 | <0.001 |
| Patient satisfaction | 2.48 ± 0.381 | 2.68 ± 0.314 | <0.001 |
Process deviations per item of both sections for control and experimental groups
| Characteristic | Control group ( | Experimental group ( |
|---|---|---|
| Items process deviations ( | ||
| Pre-procedural planning | ||
| Discussed referring physician/MDT | 2 | 0 |
| Imaging studies reviewed | 1 | 0 |
| Relevant medical history | 2 | 0 |
| Informed consent/complications discussed | 10 | 0 |
| CIN prophylaxis | 0 | 0 |
| Specific tools present/ordered | 4 | 0 |
| Fasting order given | 3 | 0 |
| Relevant lab test ordered | 0 | 0 |
| Anaesthesiologist necessary | 0 | 0 |
| Anticoagulation medication stopped | 2 | 0 |
| Post interventional (ICU) bed required | 0 | 0 |
| Treatment limitation checked | 0 | 0 |
| Total pre-procedural planning | 24 | 0 |
| Sign in | ||
| All records with patient | 0 | 0 |
| Correct patient/side/site | 0 | 0 |
| Patient fasting | 3 | 0 |
| IV access | 3 | 0 |
| Coagulation checked | 1 | 1 |
| CIN checked | 0 | 2 |
| Other lab tests checked | 0 | 0 |
| Allergies and/or prophylaxis checked | 0 | 0 |
| Antibiotics/other drugs administered | 12 | 4 |
| Total sign in | 19 | 7 |
| Total pre-procedural planning and sign in | 43 | 7 |
Overall number of process deviations per patient
| Characteristic | Control group ( | Experimental group ( |
|
|---|---|---|---|
| Process deviations (mean ± SD) | |||
| Pre-procedural planning | 0.22 ± 0.531 | 0.00 ± 0.000 | <0.001 |
| Sign in | 0.17 ± 0.425 | 0.06 ± 0.245 | 0.021 |
| Pre-procedural + sign in | 0.39 ± 0.779 | 0.06 ± 0.245 | <0.001 |